FOXO1
FOXO1 (forkhead box O1, also known as FKHR, FKH1 and FOXO1A) is a forkhead-family transcription factor and the main target of insulin signalling. It regulates metabolic homeostasis in response to oxidative stress. Browse Assay Genie's current range of FOXO1 research reagents below, or read on for the biology behind the target.
FOXO1 is a transcription factor that acts as the main target of insulin signalling and controls metabolic homeostasis under oxidative stress. It binds the insulin response element (IRE, consensus 5'-TT[G/A]TTTTG-3') and the related Daf-16 family binding element (DBE, consensus 5'-TT[G/A]TTTAC-3'). Its activity is suppressed by insulin. In hepatocytes it promotes gluconeogenesis, working with PPARGC1A and CEBPA to activate genes such as IGFBP1, G6PC1 and PCK1, and also directly driving expression of PPARGC1A and G6PC1.
The functions of FOXO1 extend well beyond the liver. It is a main regulator of redox balance and osteoblast numbers, and it controls bone mass. It helps the skeleton exert its endocrine effect on glucose metabolism, acting with ATF4 to suppress osteocalcin/BGLAP and suppressing RUNX2. When lipid levels are low, it moves to the nucleus and promotes SOX9 expression, driving chondrogenic commitment of skeletal progenitor cells. In pancreatic beta cells it represses PDX1, and in adipose tissue it regulates adipogenic genes such as PPARG during preadipocyte differentiation.
FOXO1 is also an important regulator of cell death downstream of CDK1, PKB/AKT1 and STK4/MST1. It promotes neural cell death, activates pro-apoptotic genes in cardiac smooth muscle cells, and regulates endothelial cell apoptosis through CCL2 and BCL2L11 in a PPIA/CYPA-dependent manner. It is required for autophagic cell death after starvation or oxidative stress, independently of transcription. The FOXO1 gene belongs to the forkhead family, defined by a distinct forkhead domain, and may play a role in myogenic growth and differentiation. Its earlier name, forkhead homolog in rhabdomyosarcoma, reflects the translocation of this gene with PAX3 in alveolar rhabdomyosarcoma. Mouse and rat orthologs are both named Foxo1.
FOXO1 is the main target of insulin signalling and regulates metabolic homeostasis, including gluconeogenesis through IGFBP1, G6PC1 and PCK1.
FOXO1 controls bone mass and osteoblast numbers, and drives chondrogenic commitment of skeletal progenitor cells through SOX9 when lipid levels are low.
FOXO1 acts downstream of AKT1, CDK1 and STK4/MST1 to regulate apoptosis, and is required for autophagic cell death after starvation or oxidative stress.
Translocation of the FOXO1 gene with PAX3 has been associated with alveolar rhabdomyosarcoma, making it relevant to studies of this cancer.
FOXO1 is a transcription factor and the main target of insulin signalling. It regulates metabolic homeostasis in response to oxidative stress, promotes hepatic gluconeogenesis, controls bone mass and osteoblast numbers, and regulates apoptosis and autophagic cell death in several cell types.
FOXO1 is also called FKHR, FKH1 and FOXO1A. The former name, forkhead homolog in rhabdomyosarcoma, comes from the gene's translocation with PAX3 in alveolar rhabdomyosarcoma. The HGNC gene group is Forkhead boxes, and the protein is annotated as Forkhead box protein O1.
Mouse and rat both have a Foxo1 ortholog. Translocation of the human gene with PAX3 has been associated with alveolar rhabdomyosarcoma. Check the datasheet of any product for its validated reactivity.
Other forkhead box O family members with research products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q12778; product specifications from Assay Genie datasheets.